An apparatus for tissue therapy may include a sequentially-collapsing tissue interface for use with negative pressure. The apparatus may include a first manifold and a second manifold fluidly coupled to the first manifold through a constricted fluid path. A fluid conductor may fluidly couple the second manifold to the first manifold. The fluid conductor may constrict fluid flow between the first manifold and the second manifold. The apparatus may include a negative-pressure source fluidly coupled to the first manifold in some embodiments. A controller may be configured to operate a negative-pressure source to provide negative pressure to a tissue interface in a therapy sequence adapted to propagate a wave in the tissue site. Such motion may be particularly advantageous or beneficial for a variety of conditions, including lymphedema, edema, or venous insufficiency.

Disclosed herein is a polyurethane foam sponge produced by the steps of a) providing an hydrophobic polyol which has six hydroxyl groups, b) providing a hydrophilic diisocyanate obtained by reacting a diisocyanate with a hydrophilic polyether diol, c) reacting the hydrophobic polyol with the hydrophilic diisocyanate to obtain a prepolymer which includes 3 to 6 isocyanate groups, and d) mixing the prepolymer with a hydrophilic polyether polyol, a blowing agent, an end-capping agent, a reinforcing agent, and a catalyst to obtain the polyurethane foam sponge. A wound dressing including the polyurethane foam sponge is also disclosed.

Provided are buffered adhesive compositions comprising a high molecular weight non-neutralized polymeric acid and a high molecular weight partially neutralized polymeric acid and products such as wound dressings and ostomy skin barriers incorporating the compositions.

Disclosed herein are several embodiments of a wound treatment apparatus employing glue on the backing layer of a wound dressing. In some embodiments, the glue limits saturation of an absorbent layer beneath the backing layer.

The present disclosure is directed to systems and methods that removing exogenous particles from a target region of the skin of a patient. The systems and methods can employ dermal lavage to remove the exogenous particles from the target region. In some instances, the exogenous particles can be residual tattoo ink after a tattoo removal process. A conduit can be sized and dimensioned for insertion into or around the target region to inject an irrigation fluid that defines an irrigation area. The exogenous particles can be suspended in the irrigation fluid. A device can be configured to form one or more channels in the irrigation area so that the exogenous particles are removable from the irrigation area.

The present invention provides a method and device for visualizing and treating an injury, wound or skin, using a visual tourniquet and skin bandage system made of transparent materials. The inventive bandage system is capable of applying pressure while absorbing bodily fluids away from the wound or skin and providing support for the application of one or more medicaments or a combination of treatment gas and/or medicine. The inventive bandage system enables the practitioner to visually inspect and measure the size of the wound over time without removing or touching the bandage or tourniquet thereby reducing pain and contamination of the wound bed. One embodiment of the inventive bandage system continuously controls the wound bed temperature thereby reducing pain and inhibiting bacterial growth. Other embodiments of the inventive bandage system are used as a visual tourniquet to apply a combination of pressures to a wound or skin injury.

A wound dressing, a method of manufacturing a wound dressing, and a method of treating a patient are disclosed. The wound dressing may include an absorbent layer for absorbing wound exudate; and an obscuring element for at least partially obscuring a view of wound exudate absorbed by the absorbent layer in use.

A method of manufacturing a laminated dressing that includes providing a lower layer having a fiber material that directly contacts a patient's skin and a wound area, providing an upper layer that has a foam or foam-like material that absorbs exudate and moisture, and binding the fiber-based lower layer and the foam-based upper layer with a binder layer comprising a binder material, the binder layer including a series of perforations. The perforations in the binder layer are formed by removing material from the binder layer with a pattern coated adhesive sheet prior to binding the fiber-based lower layer and the foam-based upper layer.

A medical polyurethane foam dressing and a preparation method thereof are provided in this disclosure. The medical polyurethane foam dressing includes a polyurethane film, a hydrophilic polyurethane foam layer compounded on the polyurethane film, a release paper provided on the hydrophilic polyurethane foam layer, and a soft silicone composite layer located below the release paper. The polyurethane film consists of a release film and a PU resin layer or TPU resin layer coated on the release film. Products prepared according to the disclosure not only can serve to absorb wound exudate of pressure sore, but also provides single-side water proofing; and it is sticky and can be stably fixed on the wound without easy displacement, thus ensuring continuous and stable liquid absorption.

A composite wound dressing apparatus promotes healing of a wound via the use of a micropump system housed within or above a wound dressing member. The micropump system includes a miniature pump that applies a subatmospheric pressure to the wound to effectively draw wound fluid or exudate away from the wound bed without the need for a cumbersome external vacuum source. Hence, the wound dressing and micropump system is portable which allows the patient mobility that is unavailable when an external vacuum source is used. The patient does not need to be constrained for any period of time while exudate is being removed from the wound.